MY181007A - Scale drop disease (sdd) causative virus and derivatives thereof - Google Patents

Scale drop disease (sdd) causative virus and derivatives thereof

Info

Publication number
MY181007A
MY181007A MYPI2015002848A MYPI2015002848A MY181007A MY 181007 A MY181007 A MY 181007A MY PI2015002848 A MYPI2015002848 A MY PI2015002848A MY PI2015002848 A MYPI2015002848 A MY PI2015002848A MY 181007 A MY181007 A MY 181007A
Authority
MY
Malaysia
Prior art keywords
virus
sdd
derivatives
scale drop
causative virus
Prior art date
Application number
MYPI2015002848A
Inventor
Lars Guelen
De Ad Groof
Carla Christian Schrier
Luc Grisez
Siow Foong Chang
Masato Miyata
Van Der Cornelia Maria Hoek
Martin Deijs
Kah Sing Ng
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MY181007A publication Critical patent/MY181007A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00061—Methods of inactivation or attenuation
    • C12N2710/00063—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to an isolated virus causing Scale Drop Disease in fish, to cell cultures comprising said virus, to vaccines on the basis of said virus and methods for the preparation of such a vaccine, to antibodies reactive with said virus, to diagnostic test kits for the detection of that virus and to uses of said virus.
MYPI2015002848A 2013-05-31 2014-05-28 Scale drop disease (sdd) causative virus and derivatives thereof MY181007A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13170063 2013-05-31

Publications (1)

Publication Number Publication Date
MY181007A true MY181007A (en) 2020-12-15

Family

ID=48536728

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015002848A MY181007A (en) 2013-05-31 2014-05-28 Scale drop disease (sdd) causative virus and derivatives thereof

Country Status (5)

Country Link
CN (2) CN110438090B (en)
AU (1) AU2014273183B2 (en)
MY (1) MY181007A (en)
SG (1) SG11201509830UA (en)
WO (1) WO2014191445A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201900912PA (en) 2016-08-11 2019-02-27 Intervet Int Bv Novel fish pathogenic virus
CN108315487B (en) * 2018-04-16 2021-06-22 福建省农业科学院生物技术研究所 Primer group and kit for detecting eel herpesvirus and application of primer group and kit
CN111621550B (en) * 2020-06-18 2021-08-10 中国水产科学研究院黄海水产研究所 RPA reaction system suitable for rapid detection of mermaid subspecies of mermaid photobacterium
CN114106112B (en) * 2021-11-30 2023-07-07 西北农林科技大学 Truncated expressed Mandarin infectious spleen and kidney necrosis virus main capsid protein and application thereof
CN116121197B (en) * 2022-09-28 2023-10-20 华南农业大学 Monoclonal antibodies against isolates of yellowfin seabream iridovirus SDDV and their applications
CN116004483B (en) * 2023-03-09 2023-06-02 四川厌氧生物科技有限责任公司 Lactococcus garvieae for preventing or treating diarrhea and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0195792A (en) * 1987-10-07 1989-04-13 Sapporo Breweries Ltd Novel substance 46nw-04a, production thereof and antiviral pharmaceutical containing said substance as active ingredient
EP0382271B1 (en) 1989-02-04 1994-12-21 Akzo Nobel N.V. Tocols as adjuvant in vaccine
WO1998042204A1 (en) * 1997-03-21 1998-10-01 Kabushiki Kaisha Yakult Honsha Infectious disease preventive/remedy for fishes and shellfishes
DE69910253T2 (en) 1998-12-21 2004-06-17 Akzo Nobel N.V. METHOD FOR PRODUCING INACTIVATED, W / O EMULSION ADJUVED, VACCINALS
WO2002022664A2 (en) * 2000-09-15 2002-03-21 Akzo Nobel N.V. Antigenic proteins of shrimp white spot syndrome virus and uses thereof
US8343505B2 (en) * 2007-12-04 2013-01-01 Schweitzer Co., Ltd. Subunit vaccine for aquaculture
CN101507774B (en) * 2009-03-20 2010-12-01 宫玉泰 Traditional Chinese medicine for treating ichthyosis
EP2688587B2 (en) * 2011-03-25 2023-08-16 Intervet International B.V. Salmonid alphavirus vaccine

Also Published As

Publication number Publication date
CN110438090B (en) 2023-12-05
CN110438090A (en) 2019-11-12
SG11201509830UA (en) 2015-12-30
AU2014273183A1 (en) 2015-11-19
WO2014191445A1 (en) 2014-12-04
CN105247043A (en) 2016-01-13
AU2014273183B2 (en) 2017-01-19

Similar Documents

Publication Publication Date Title
MX2021000435A (en) BISPECIFIC MOLECULES THAT ARE IMMUNOREACTIVE WITH IMMUNE EFFECTOR CELLS THAT EXPRESS AN ACTIVATOR RECEPTOR AND AN ANTIGEN EXPRESSED BY A CELL INFECTED BY A VIRUS AND USES THEREOF.
CL2018001051A1 (en) Nucleic acid vaccines against varicella zoster virus (vzv)
Belser et al. H5N1 pathogenesis studies in mammalian models
MY181007A (en) Scale drop disease (sdd) causative virus and derivatives thereof
HUE041854T2 (en) Methods and solid carriers for sample preparation using transposomes
BR112017001579A2 (en) anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable cd3 antibodies and methods of use
WO2015109323A3 (en) Systems and methods for three-dimensional imaging
CL2016001102A1 (en) Novel anti-claudin antibodies and methods of use.
HUE053545T2 (en) Human immunodeficiency virus neutralizing antibodies and methods for their use
HUE057521T2 (en) Preparations and methods for propagating and culturing epithelial stem cells
MX350274B (en) Vaccines for hsv-2.
BR112016013562A2 (en) HUMANIZED ANTI-TAU(PS422) ANTIBODIES, THEIR USES, AND PHARMACEUTICAL FORMULATIONS
AR093446A1 (en) ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE
BR112017009764A2 (en) bispecific antibodies and methods of use in ophthalmology
AR091582A1 (en) VACCINES ATTENDED AGAINST STREPTOCOCCUS SUIS AND METHODS OF ELABORATION AND USE OF THE SAME
MX391037B (en) HUMAN-DERIVED ANTI-HUNTINGTIN (HTT) ANTIBODIES AND THEIR USES.
EA201590829A1 (en) NEW FLOURED ADJUVANTS AND DELIVERY SYSTEMS
MX378905B (en) PESTIVIRUS.
MX383506B (en) SWINE PARVOVIRUS.
BR112015003032A8 (en) isolated antibodies, isolated nucleic acids, host cell, method of producing an antibody, immunoconjugate, pharmaceutical formulation, use of the antibody and method of treatment of an individual.
AR094810A1 (en) PARVOVIRUS PORCINO 5B, METHODS OF USE AND VACCINE
MX2014015766A (en) Toll-like receptors and immunostimulatory oligonucleotides.
ES2503516R1 (en) IMMUNOGENIC COMPLEX FOR VACCINATION AND METHOD OF OBTAINING
BR112017003979A2 (en) method for the preparation of a vaccine antigen, vaccine likely to be produced by the implementation of the method, and use of a calixeene
WO2015061610A3 (en) Human t cell line assay for evaluating the immunologic identity of glatiramer acetate preparations